Bluejay Diagnostics (BJDX) Other financing activities (2021 - 2026)

Bluejay Diagnostics' Other financing activities history runs 6 years deep, the most recent figure standing at $1051.0 for Q1 2026.

• In Q1 2026, Other financing activities rose 6.7% year-over-year to $1051.0; the TTM figure through Mar 2026 stood at $1.3 million (up 10.41% YoY), while the FY2025 annual figure was $1.3 million, down 32.1% from the prior year.
• Other financing activities came in at $1051.0 for Q1 2026 at Bluejay Diagnostics, down from $1.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.8 million in Q4 2024 to a low of -$709187.0 in Q2 2024.
• A 5-year average of $249578.0 and a median of $27702.0 in 2023 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities soared 59053.99% in 2024 and slumped 48851.43% in 2025, its largest moves.
• Bluejay Diagnostics' Other financing activities stood at $106114.0 in 2022, then tumbled by 127.24% to -$28904.0 in 2023, then surged by 6471.64% to $1.8 million in 2024, then slumped by 32.16% to $1.2 million in 2025, then plunged by 99.92% to $1051.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $1051.0, $1.2 million, and -$461676.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison